Summary#
The Agricultural Biotechnology Coordination Act would amend the Department of Agriculture Reorganization Act of 1994. It would require the Agriculture Secretary to create an Office of Biotechnology Policy inside the Department of Agriculture (USDA); the bill’s stated aim is to prioritize biotechnology through better coordination. It has been introduced in the Senate and is not law.
- The Secretary must establish the office and appoint a director who reports directly to the Secretary or the Secretary’s designee.
- The office must develop and coordinate USDA policies, activities, and services on biotechnology and related topics, including research and development; communication, extension, and education; regulation and labeling; and commercialization, use, and trade.
- The office must assist other USDA offices and agencies with their biotechnology-related legal responsibilities. It may also take on other duties required by law or considered appropriate by the Secretary.
- The office must lead coordination with the Environmental Protection Agency, the Food and Drug Administration, and other relevant federal and state agencies.
- The office must consult, as necessary, with biotechnology developers, academics, agricultural producers, and other entities that may be affected.
What it means for you#
- USDA and other agencies: USDA would have a new office to coordinate its biotechnology work. The office would lead coordination with EPA, FDA, and other relevant federal and state agencies, but the bill does not transfer those agencies’ legal powers to it.
- Agricultural producers, developers, academics, and other affected entities: The office must consult these groups as necessary. The bill does not guarantee that every person or organization in these groups will be consulted.
- The public: The office would work on policy areas that include regulation and labeling, but the bill does not itself change any specific regulation, label, or product requirement.
- The office would be part of USDA, not a separate agency. The bill does not create a new benefit, fee, fine, or direct service for the public.
Money#
No cost information is in the available material.
- The bill requires USDA to establish the office and have it headed by a director, but does not specify staffing levels or costs.
- It adds authority for the Secretary to carry out the new section, but provides no appropriation or dollar amount.
What is unclear#
- The bill does not define “biotechnology,” “related topics,” or “other relevant” agencies.
- It does not set timelines, decision rules, reporting requirements, or a process for resolving disagreements between agencies.
- “Consult as necessary” does not specify when consultation is required or how it must be carried out.
- The bill does not explain how the new office would divide work with existing USDA offices. The Department of Agriculture Reorganization Act of 1994 was not supplied, so the existing structure and any overlap with current offices could not be verified.
- The bill does not say how the office’s work would affect existing federal or state programs.
Case for#
- The bill appears intended to improve coordination of USDA work on biotechnology across research, education, regulation, trade, and other areas.
- A central office could give USDA a clear point of coordination with EPA, FDA, and state agencies.
- Requiring consultation with producers, researchers, developers, and other affected entities could bring their views into the Department’s work.
Case against#
- The bill does not define key terms or explain how the office’s duties would fit with existing USDA offices and other agencies’ responsibilities.
- It requires coordination and consultation but sets few rules for how either must happen, making the office’s practical role hard to predict.
- The Secretary may assign other duties considered appropriate, but the bill does not set limits or require public reporting on those duties.